MRI sequence
OtherThis sequence is a 2D spin-echo sequence for the generation of synthetic maps
NCT Number: NCT06916182
Inflammatory optic neuropathy (optic neuritis) is an acute condition that can affect the optic nerve along its entire course.
It is a rare event, with a prevalence of up to 5 cases per 100,000 people per year, predominantly affecting young individuals (18-50 years old), primarily Caucasian and female. The causes of optic neuropathy are diverse, with the most common being multiple sclerosis, which is the revealing condition in nearly 30% of cases.
MRI is an integral part of the initial assessment of optic neuritis, in conjunction with clinical examination, laboratory tests, and OCT (optical coherence tomography). It plays a crucial role in the acute management of this condition, particularly by guiding the etiological diagnosis and helping adapt the therapeutic approach accordingly.
The establishment of objective and reliable MRI prognostic markers could allow for more precise immediate therapeutic adjustments, thereby improving the prognosis of this potentially severe and debilitating disease, whose treatment itself is not without risks. Indeed, determining the appropriate corticosteroid dose and deciding whether to combine it with other treatments remains a current clinical challenge.
Despite various publications, MRI prognostic criteria for short- and long-term outcomes of optic neuritis remain unclear. Recent studies using radiomics have shown promising results, but these rely on limited sample sizes. New investigative methods are currently under development in the field of medical imaging, particularly "quantitative MRI."
This approach enables effective analysis through mapping techniques, which generate numerical values compared to predetermined references. For instance:
T1 (or R1) mapping assesses fibrosis and, indirectly, myelination, T2 (or R2) mapping evaluates edema. To our knowledge, this approach has never been studied for the optic nerve.
More recently, the emergence of synthetic imaging has made it possible to generate the previously mentioned R1/R2 maps, along with more conventional weighted images (T1, T2, FLAIR, DP), from a single MRI sequence (2D spin-echo sequence). This sequence provides quantitative values while maintaining a short acquisition time (~5 minutes), which is essential in ophthalmologic imaging, where motion artifacts are frequent.
The goal of this study is to identify prognostic criteria for the evolution of optic neuritis using synthetic quantitative MRI sequences, in the form of threshold numerical values.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This sequence is a 2D spin-echo sequence for the generation of synthetic maps
Time frame: 4 months after inclusion
Visual function will be categorized into four stages:
Definitions:
Normal visual acuity:
Normal visual field: Mean deviation (MD) > -3 dB.
Normal OCT (ganglion cell layer and pRNFL):
Values within the normal range according to the manufacturer's reference data, adjusted for age.
Contact information is provided by the study sponsor or research team.
Fondation Ophtalmologique Adolphe de Rothschild
Network
Acronym: QUESTION
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07704294
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
London, United Kingdom
View Trial DetailsNCT07100990
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Scottsdale, Arizona, United States
View Trial DetailsNCT07623668
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Livonia, Michigan, United States
View Trial DetailsNCT07623252
Cranial Nerve Diseases, Eye Diseases
Nanning, Guangxi, China
View Trial Details